ClinicalTrials.Veeva

Menu

The Role of Ninjurin-1 During Systemic Inflammation (Ninj1)

D

Dr. Patrick Meybohm, M.D.

Status

Completed

Conditions

Ninj1 Expression
SIRS

Study type

Observational

Funder types

Other

Identifiers

NCT02079597
NINJ1-001

Details and patient eligibility

About

  • With the underlying study the investigators address the question if Ninjurin-1 (Ninj1) expression is altered in patients with systemic inflammatory response syndrome (SIRS) in comparison to healthy volunteers.
  • The adhesion molecule Ninj1 is induced following nerve injury where it contributes to nerve generation. Besides it is described to facilitate leukocyte migration especially in the nervous system.
  • The investigators hypothesize that Ninj1 expression is increased in SIRS patients, which will fortify its impact during inflammation and the transferability from bench to bedside.

Enrollment

30 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • age > 18 years
  • cardiac surgery patients

Exclusion criteria

  • included in an interventional study
  • Preoperative Infection (e.g. Endocarditis)

Trial design

30 participants in 2 patient groups

Healthy
Description:
Healthy individuals no infection
SIRS
Description:
SIRS patients no included in an interventional study no peroperative infection

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems